Know Labs, Inc. , a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and ...

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers who use them to monitor their exercise, sleep and heart ...

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

Oura CEO Tom Hale spoke to CNBC about the smart ring product category and the impact of Samsung’s entrance into the space.

Dr Jagadish J Hiremath, public health intellectual, mentions, “Continuous Glucose Monitors (CGMs) are devices that provide real-time glucose readings.” ...

A novel system combining high-speed video and AI algorithms could revolutionize health screenings for high blood pressure and ...